The latest news from The VIVA Foundation
Don’t miss a thing! Sign up to get the latest announcements, important dates, and news.
News & Updates
Vascular Innovation Takes Center Stage at The VEINS and VIVA 2026
August 6, 2026The VIVA Foundation will spotlight the latest advances in vascular medicine as 26 clinical trials are presented during The VEINS and VIVA 2026, taking place October 3-6 at Bellagio Las Vegas. The highly anticipated late-breaking presentations will provide attendees with early access to new evidence shaping the future o ...
News & Updates
Dr. Robert A Lookstein Appointed to The VIVA Foundation Board of Directors
July 1, 2026The VIVA Foundation is pleased to announce the appointment of Dr. Robert A. Lookstein, MD, MHCDL, FSIR, FAHA, FSVM, to its Board of Directors. A nationally recognized leader in interventional radiology, Dr. Lookstein serves as Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai and Executi ...
News & Updates
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA 2025
November 4, 2025The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, today announced results from the fourth and final round of Late-Breaking Clinical Trials presented at VIVA 2025, held at Wynn Las Vegas. VIVA (Vascular InterVentional ...
News & Updates
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA 2025
November 4, 2025The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, today announced results from the third round of Late-Breaking Clinical Trials presented at VIVA 2025, held at Wynn Las Vegas. VIVA (Vascular InterVentional Advances) ...
News & Updates
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA 2025
November 3, 2025The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, today announced results from the second round of Late-Breaking Clinical Trials presented at VIVA 2025, held at Wynn Las Vegas. VIVA (Vascular InterVentional Advances) ...